Rare essentials: drugs for rare diseases as essential medicines.

Abstract

Since 1977, the WHO Model List of Essential Medicines (EML), published by WHO, has provided advice for Member States that struggle to decide which pharmaceutical technologies should be provided to patients within their public health systems. Originating from outside WHO, an incentive system has been put in place by various governments for the development of… (More)

Topics

4 Figures and Tables

Cite this paper

@article{Stolk2006RareED, title={Rare essentials: drugs for rare diseases as essential medicines.}, author={Pieter Stolk and Marjolein J C Willemen and Hubert G. M. Leufkens}, journal={Bulletin of the World Health Organization}, year={2006}, volume={84 9}, pages={745-51} }